We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+4.45%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$682M
AUM Growth
-$57.4M
(-7.8%)
Cap. Flow
-$58.6M
Cap. Flow
% of AUM
-8.59%
Top 10 Holdings %
Top 10 Hldgs %
43.46%
Holding
272
New
71
Increased
40
Reduced
49
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Truist Financial
TFC
|
+$10M |
| 2 |
Analog Devices
ADI
|
+$8.69M |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$8.43M |
| 4 |
Progressive
PGR
|
+$8.24M |
| 5 |
RXO
RXO
|
+$8.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$13.9M |
| 2 |
AJRD
Aerojet Rocketdyne Holdings
AJRD
|
+$11.2M |
| 3 |
CMA
Comerica
CMA
|
+$10.7M |
| 4 |
Wells Fargo
WFC
|
+$10.6M |
| 5 |
Allstate
ALL
|
+$10.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.7% |
| 2 | Financials | 23.13% |
| 3 | Technology | 17.28% |
| 4 | Industrials | 11.23% |
| 5 | Materials | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Denali Therapeutics
DNLI
$3.65B
| $191M | 27.96% |
6,860,732
-300,000
| -4% | -$8.93M |
|
2
Broadcom
AVGO
$1.85T
| $15.7M | 2.3% |
280,330
+96,090
| +52% | +$4.82M |
|
3
NCR Voyix
VYX
$1.14B
| $14.3M | 2.1% |
997,149
+174,881
| +21% | +$2.33M |
|
4
Sana Biotechnology
SANA
$871M
| $13.3M | 1.95% |
3,365,624
| – | – |
|
|
5
Analog Devices
ADI
$179B
| $12.4M | 1.82% |
75,523
+55,659
| +280% | +$8.69M |
|
6
American International
AIG
$41.7B
| $10.9M | 1.59% |
172,082
+72,082
| +72% | +$4.19M |
|
|
WCC
7
WESCO International
WCC
$16.7B
| $10.5M | 1.53% |
83,614
+29,953
| +56% | +$3.77M |
|
8
Mirion Technologies
MIR
$3.73B
| $9.92M | 1.45% |
1,500,010
+376,153
| +33% | +$2.53M |
|
|
9
Truist Financial
TFC
$63.3B
| $9.85M | 1.44% |
+229,000
| New | +$10M |
|
10
ESAB
ESAB
$5.38B
| $8.99M | 1.32% |
191,548
-18,452
| -9% | -$772K |
|
11
APi Group
APG
$17.1B
| $8.84M | 1.3% |
705,000
-20,717
| -3% | -$239K |
|
|
12
Progressive
PGR
$123B
| $8.43M | 1.24% |
+65,000
| New | +$8.24M |
|
|
FITB
13
Fifth Third Bancorp
FITB
$51.2B
| $8.1M | 1.19% |
+246,821
| New | +$8.43M |
|
14
Royal Gold
RGLD
$16.8B
| $8.04M | 1.18% |
71,361
-616
| -0.9% | -$63.5K |
|
|
15
RXO
RXO
$3.34B
| $7.85M | 1.15% |
+456,159
| New | +$8.09M |
|
16
Arcosa
ACA
$7.13B
| $7.61M | 1.11% |
140,000
+50,000
| +56% | +$2.97M |
|
17
Spectrum Brands
SPB
$2.04B
| $7.31M | 1.07% |
120,000
+40,000
| +50% | +$2.02M |
|
18
Cullen/Frost Bankers
CFR
$10.3B
| $7.12M | 1.04% |
53,270
+20,270
| +61% | +$2.88M |
|
19
Cboe Global Markets
CBOE
$32.5B
| $6.95M | 1.02% |
55,416
+25,416
| +85% | +$3.14M |
|
20
CME Group
CME
$96.3B
| $6.73M | 0.99% |
+40,000
| New | +$6.95M |
|
21
BWX Technologies
BWXT
$15.5B
| $6.44M | 0.94% |
110,897
+897
| +0.8% | +$51.5K |
|
22
Franco-Nevada
FNV
$41.1B
| $6.31M | 0.92% |
46,200
+2,978
| +7% | +$393K |
|
23
Cameco
CCJ
$37.6B
| $6.3M | 0.92% |
+277,680
| New | +$6.53M |
|
24
Ameriprise Financial
AMP
$48.3B
| $6.29M | 0.92% |
+20,208
| New | +$6.16M |
|
25
Agnico Eagle Mines
AEM
$73.6B
| $6.28M | 0.92% |
120,817
-22,083
| -15% | -$1.04M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q4 2022 Portfolio in Review
As of Q4 2022, Crestline Management held 272 positions worth $682M, down 7.8% from $740M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Crestline Management withdrew a net $58.6M in Q4 2022, closing 107 positions and reducing 49 holdings. Its most notable exit was US Bancorp, an estimated $13.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Financials and Technology.
Against the trend, Crestline Management opened a new position in Truist Financial worth $9.85M.
- Crestline Management's largest Q4 2022 buy was Truist Financial: 229,000 shares worth $9.85M.
- Crestline Management added most to Analog Devices in Q4 2022, an estimated $8.69M increase.
- Crestline Management's biggest Q4 2022 reduction was Wells Fargo, cutting an estimated $10.6M.
- Crestline Management fully exited US Bancorp in Q4 2022, selling an estimated $13.9M.
- Crestline Management's ten largest holdings make up 43% of its $682M portfolio in Q4 2022.
- Crestline Management opened 71 new positions and closed 107 in Q4 2022.
- Crestline Management's portfolio value fell 7.8% quarter-over-quarter to $682M.
Based on Crestline Management's 13F filing for Q4 2022, filed 13 Feb 2023.